Skip to main content
OpenTrials
Recruiting

NCT Number: NCT02784977

TURKAPNE - The Turkish Sleep Apnea Database: A National, Multicenter, Observational, Prospective Cohort Study

Primary aim of the TURKAPNE (The Turkish Sleep Apnea Database) study is to generate a cross-sectional nationwide database to define clinical and polysomnographic characteristics of the sleep apnea patients in Turkey. Associations of phenotypes of sleep apnea patients with metabolic and cardiovascular diseases as well as risk for traffic accidents will be explored as secondary aims. Impact of treatment of sleep apnea on metabolic and cardiovascular complications as well as compliance with positive airway pressure treatment will be further explored longitudinally.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

All subjects undergoing sleep study for suspicion of obstructive sleep apnea will be registered in a web-based national database regarding:

  • Anthropometric data, educational status, driving licence,
  • Smoking and alcohol use
  • Comorbidities, and drug use
  • Questionnaires, excessive daytime sleepiness
  • Polygraphic and polysomnographic findings
  • Blood pressure measurements
  • If taken, blood glucose, lipids and other biochemical markers
  • If measured, lung function test results
  • If measured, echocardiography findings
  • Follow-up data regarding treatment modality and compliance

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Consecutive adult patients undergoing sleep study for suspicion of obstructive sleep apnea
  • Ability to read and speak
  • Signed informed consent.

Exclusion criteria

  • subjects who use positive airway pressure
  • subjects with limited life expectancy due to advanced renal disease or uncontrolled malignancies
  • subjects with alcohol dependency

Treatment and study plan

Positive Airway Pressure (PAP)

Device

Treatment of OSA with PAP

Intraoral device (IOD)

Device

Treatment of OSA with IOD

Uvuloplasty

Procedure

Uvuloplasty

Conservative treatment

Other

No active intervention

Primary outcomes

  1. Metabolic and cardiovascular diseases in obstructive sleep apnea phenotypes

    Time frame: Up to three years

    The association of sleep apnea severity indices such as Apnea-Hypopnea Index and Oxygen Desaturation Index during Rapid Eye Movement (REM) sleep and non-REM sleep with self-reported diabetes mellitus and cardiovascular diseases will be explored.

Secondary outcomes

  1. Sex differences in obstructive sleep apnea phenotypes

    Time frame: Up to three years

    Possible sex differences in REM-dependent sleep apnea, positional sleep apnea and its association with metabolic and cardiovascular diseases will be explored

  2. Adherence to positive airway pressure treatment in obstructive sleep apnea

    Time frame: Through study completion, an average of 7 years

    Predictors of adherence to positive airway pressure treatment (defined as device usage at least 4 hours of night during at least 70% of study period) in obstructive sleep apnea

  3. Incidence of cardiovascular diseases and mortality

    Time frame: Through study completion, an average of 7 years

    Number of patients who have died or developed cardiovascular diseases

Study contacts

Contact information is provided by the study sponsor or research team.

Baran Balcan, Assoc. Prof

CONTACT

[email protected]

+905304142308

Yüksel Peker, Prof

CONTACT

[email protected]

+905443483866

Sponsors and collaborators

Lead sponsor

Koç University

Other

Collaborators

  • Afyon Kocatepe University School of Medicine, Afyon, Turkey
  • Baskent University Ankara Hospital
  • Dicle University School of Medicine, Diyarbakir, Turkey
  • Diskapi Yildirim Beyazit Education and Research Hospital
  • Dokuz Eylul University
  • Ege University School of Medicine, Izmir, Turkey
  • Hitit University School of Medicine, Corum, Turkey
  • Istanbul Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital
  • Istanbul University - Cerrahpasa
  • Kocaeli Education and Research Hospital, Kocaeli, Turkey
  • Marmara University
  • Namik Kemal University School of Medicine, Tekirdag
  • Pamukkale University School of Medicine, Denizli, Turkey
  • Suleyman Demirel University School of Medicine, Isparta, Turkey
  • Trakya University
  • Uludag University

Registry information

Acronym: TURKAPNE

Important dates

Study start
2017
Primary completion
2024
Study completion
2027
First posted
May 27, 2016
Registry last updated
Oct 13, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.